Abdalla MMI (2024) Insulin resistance as the molecular link between diabetes and Alzheimer’s disease. World J Diabetes 15(7):1430–1447. https://doi.org/10.4239/wjd.v15.i7.1430
Article PubMed PubMed Central Google Scholar
Abdyeva A, Kurtova E, Savinkova I, Galkov M, Gorbacheva L (2024) Long-term exposure of cultured astrocytes to high glucose impact on their LPS-induced activation. Int J Mol Sci. https://doi.org/10.3390/ijms25021122
Article PubMed PubMed Central Google Scholar
Abyadeh M, Gupta V, Paulo JA, Mahmoudabad AG, Shadfar S, Mirshahvaladi S, Gupta V, Nguyen CTO, Finkelstein DI, You Y, Haynes PA, Salekdeh GH, Graham SL, Mirzaei M (2024) Amyloid-beta and tau protein beyond Alzheimer’s disease. Neural Regen Res 19(6):1262–1276. https://doi.org/10.4103/1673-5374.386406
Article CAS PubMed Google Scholar
Ahtiluoto S, Polvikoski T, Peltonen M (2010) Diabetes, Alzheimer disease, and vascular dementia. Neurology. https://doi.org/10.1212/WNL.0b013e3181f4d7f8
Albitar O, D’Souza CM, Adeghate EA (2024) Effects of lipoproteins on metabolic health. Nutrients 16(13):1–15. https://doi.org/10.3390/nu16132156
Alfei S, Schito GC, Schito AM, Zuccari G (2024) Reactive oxygen species (ROS)-mediated antibacterial oxidative therapies: available methods to generate ROS and a novel option proposal. Int J Mol Sci. https://doi.org/10.3390/ijms25137182
Article PubMed PubMed Central Google Scholar
Alrouji M, Al-Kuraishy HM, Al-Gareeb AI, Alexiou A, Papadakis M, Saad HM, Batiha GES (2023) The potential role of human islet amyloid polypeptide in type 2 diabetes mellitus and Alzheimer’s diseases. Diabetol Metab Syndr 15(1):1–16. https://doi.org/10.1186/s13098-023-01082-1
Arjunan A, Sah DK, Woo M, Song J (2023) Identification of the molecular mechanism of insulin-like growth factor-1 (IGF-1): a promising therapeutic target for neurodegenerative diseases associated with metabolic syndrome. Cell Biosci 13(1):1–18. https://doi.org/10.1186/s13578-023-00966-z
Arnold SE, Arvanitakis Z, Macauley-rambach SL, Koenig AM, Stoeckel LE, Holtzman DM, Nathan DM, Street H (2018) HHS Public Access 14(3):168–181. https://doi.org/10.1038/nrneurol.2017.185.Brain
Avitan I, Halperin Y, Saha T, Bloch N, Atrahimovich D, Polis B, Samson AO, Braitbard O (2021) Towards a Consensus on Alzheimer’s Disease Comorbidity? J Clin Med 10(19):4360. https://doi.org/10.3390/jcm10194360
Azam MS, Wahiduzzaman M, Reyad-ul-Ferdous M, Islam MN, Roy M (2022) Inhibition of insulin degrading enzyme to control diabetes mellitus and its applications on some other chronic disease: a critical review. Pharm Res 39(4):611–629. https://doi.org/10.1007/s11095-022-03237-7
Article CAS PubMed Google Scholar
Azargoonjahromi A (2024) The duality of amyloid-β: its role in normal and Alzheimer’s disease states. Mol Brain 17(1):1–24. https://doi.org/10.1186/s13041-024-01118-1
Banks WA, Owen JB, Erickson MA (2012) Pharmacology & therapeutics insulin in the brain : there and back again. Pharmacol Ther 136(1):82–93. https://doi.org/10.1016/j.pharmthera.2012.07.006
Article CAS PubMed PubMed Central Google Scholar
Baranello RJ, Bharani KL, Padmaraju V, Chopra N, Lahiri DK, Greig NH, Pappolla MA, Sambamurti K, Alzheimer C, Author R (2015) Amyloid-Beta Protein Clearance and Degradation (ABCD) Pathways and their Role in Alzheimer’s Disease HHS Public Access Author manuscript. Curr Alzheimer Res 12(1):32–46
Article CAS PubMed PubMed Central Google Scholar
Barone E, Di Domenico F, Perluigi M, Butterfield DA (2021) The interplay among oxidative stress, brain insulin resistance and AMPK dysfunction contribute to neurodegeneration in type 2 diabetes and Alzheimer disease. Free Radic Biol Med 176:16–33. https://doi.org/10.1016/j.freeradbiomed.2021.09.006
Article CAS PubMed PubMed Central Google Scholar
Batista AF, Forny-Germano L, Clarke JR, Lyra e Silva NM, Brito-Moreira J, Boehnke SE, Winterborn A, Coe BC, Lablans A, Vital JF, Marques SA, Martinez AMB, Gralle M, Holscher C, Klein WL, Houzel JC, Ferreira ST, Munoz DP, De Felice FG (2018) The diabetes drug liraglutide reverses cognitive impairment in mice and attenuates insulin receptor and synaptic pathology in a non-human primate model of Alzheimer’s disease. J Pathol 245(1):85–100. https://doi.org/10.1002/path.5056
Article CAS PubMed PubMed Central Google Scholar
Beard E, Lengacher S, Dias S, Magistretti PJ, Finsterwald C (2022) Astrocytes as Key Regulators of Brain Energy Metabolism: New Therapeutic Perspectives. Front Physiol 12(January). https://doi.org/10.3389/fphys.2021.825816
Bhaskar K, Konerth M, Kokiko-cochran ON, Cardona A, Ransohoff RM, Lamb BT (2010) Article regulation of tau pathology by the microglial fractalkine receptor. Neuron 68(1):19–31. https://doi.org/10.1016/j.neuron.2010.08.023
Article CAS PubMed PubMed Central Google Scholar
Biessels GJ, Despa F (2018) Cognitive decline and dementia in diabetes mellitus: mechanisms and clinical implications. Nat Rev Endocrinol 14(10):591–604. https://doi.org/10.1038/s41574-018-0048-7
Article PubMed PubMed Central Google Scholar
Bomfim TR, Forny-Germano L, Sathler LB, Brito-Moreira J, Houzel JC, Decker H, Silverman MA, Kazi H, Melo HM, McClean PL, Holscher C, Arnold SE, Talbot K, Klein WL, Munoz DP, Ferreira ST, De Felice FG (2012) An anti-diabetes agent protects the mouse brain from defective insulin signaling caused by Alzheimer’s disease-associated Aβ oligomers. J Clin Invest 122(4):1339–1353. https://doi.org/10.1172/JCI57256
Article CAS PubMed PubMed Central Google Scholar
Bonds JA, Shetti A, Bheri A, Chen Z, Disouky A, Tai L, Mao M, Head BP, Bonini MG, Haus JM, Minshal RD, Lazarov O (2019) Depletion of caveolin-1 in type 2 diabetes model induces alzheimer’s disease pathology precursors. J Neurosci 39(43):8576–8583. https://doi.org/10.1523/JNEUROSCI.0730-19.2019
Article CAS PubMed PubMed Central Google Scholar
Boonstra J, Post JA (2004) Molecular events associated with reactive oxygen species and cell cycle progression in mammalian cells. Gene 337(SUPPL):1–13. https://doi.org/10.1016/j.gene.2004.04.032
Article CAS PubMed Google Scholar
Borek-Dorosz A, Pieczara A, Orleanska J, Brzozowski K, Tipping W, Graham D, Bik E, Kubrak A, Baranska M, Majzner K (2024) Raman microscopy reveals how cell inflammation activates glucose and lipid metabolism. Biochimica et Biophysica Acta (BBA) - Molecular Cell Research 1871(1):119575. https://doi.org/10.1016/j.bbamcr.2023.119575
Article CAS PubMed Google Scholar
Botella Lucena P, Heneka MT (2024) Inflammatory aspects of Alzheimer’s disease. Acta Neuropathol 148(1). https://doi.org/10.1007/s00401-024-02790-2
Bozelli JC, Azher S, Epand RM (2021) Plasmalogens and chronic inflammatory diseases. Front Physiol 12(October):1–19. https://doi.org/10.3389/fphys.2021.730829
Brothwell D (2005) Diseases. Antiquity. https://doi.org/10.1017/S0003598X00113821
Cai Z, Xiao M, Chang L, Yan LJ (2015) Role of insulin resistance in Alzheimer’s disease. Metab Brain Dis 30(4):839–851. https://doi.org/10.1007/s11011-014-9631-3
Article CAS PubMed Google Scholar
Campbell JM, Stephenson MD, Courten B, De, Chapman I, Bellman SM, Aromataris E (2018) Un co rre cte d Au tho r P roo f Metformin Use Associated with Reduced cte d Au tho r P roo f Un. https://doi.org/10.3233/JAD-180263
Cerasuolo M, Auriemma MC, Meo I, Di, Lenti C, Papa M, Paolisso G, Rizzo MR (2025) Understanding the Insulin-Degrading Enzyme: A New Look at Alzheimer ’ s Disease and A β Plaque Management. 1–18
Chauhan V, Chauhan A (2006) Oxidative stress in Alzheimer’s disease. Pathophysiology 13(3):195–208. https://doi.org/10.1016/j.pathophys.2006.05.004
Article CAS PubMed Google Scholar
Chauhan A, Dubey S, Jain S (2024) Association between type 2 diabetes mellitus and Alzheimer’s disease: common molecular mechanism and therapeutic targets. Cell Biochem Funct. https://doi.org/10.1002/cbf.4111
Chen H, Chan DC (2017) Review mitochondrial dynamics in regulating the unique phenotypes of cancer and stem cells. Cell Metab. https://doi.org/10.1016/j.cmet.2017.05.016
Comments (0)